Variables | MBL levels (μg/ml), median (IQR) | MBL2low-producing genotype, n (%) | Ficolin-2 levels (μg/ml), mean (SD) |
---|---|---|---|
Skin manifestations | Â | Â | Â |
Calcinosis (yes vs. no) | 2.1 (0.7-3.2) vs. 0.8 (0.1-2.1) | 2 (7) vs. 16 (27) | 0.6 (0.3) vs. 0.6 (0.3) |
  P value | 0.005 | 0.02 | 0.9 |
Pitting (yes vs. no) | 1.8 (0.5-3.0) vs. 0.8 (0.1-1.9) | 6 (13) vs. 12 (29) | 0.6 (0.4) vs. 0.5 (0.3) |
  P value | 0.007 | 0.06 | 0.2 |
Digital ulcers (yes vs. no) | 2.7 (1.0-4.1) vs. 1.0 (0.2-2.3) | 1 (8) vs. 17 (22) | 0.6 (0.4) vs. 0.6 (0.3) |
  P value | 0.01 | 0.2 | 0.5 |
Organ involvement | Â | Â | Â |
PAH (yes vs. no) | 1.7 (0.3-3.8) vs. 1.1 (0.3-2.6) | 1 (13) vs. 17 (21) | 0.5 (0.2) vs. 0.6 (0.4) |
  P value | 0.5 | 1 | 0.6 |
ILD (yes vs. no) | 1.7 (0.5-2.9) vs. 0.9 (0.2-2.1) | 6 (15) vs. 12 (25) | 0.7 (0.3) vs. 0.5 (0.3) |
  P value | 0.11 | 0.3 | 0.04 |
Renal crisis (yes vs. no) | 1.7 (0.2-4.1) vs. 1.1 (0.3-2.6) | 1 (25) vs. 17 (20) | 1.0 (0.3) vs. 0.6 (0.3) |
  P value | 0.6 | 1 | 0.01 |
Bowel dysmotility (yes vs. no) | 3.1 (0.8-4.2) vs. 1.1 (0.3-2.4) | 1 (11) vs. 17 (21) | 0.6 (0.3) vs. 0.4 (0.2) |
  P value | 0.14 | 0.7 | 0.04 |